Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Manufacturing deals
Manufacturing
J&J agrees to pay $50M to settle contract dispute with Emergent
J&J will pay Emergent $50 million to settle a two-year contract squabble over the production of COVID-19 vaccines.
Kevin Dunleavy
Jul 9, 2024 10:17am
Evotec, Sandoz expand biosimilar production pact inked last year
Jul 9, 2024 8:25am
Lotte Biologics, Merck KGaA partner for biopharma production
Jun 3, 2024 1:38pm
Astellas, Yaskawa to explore automated cell therapy production
May 21, 2024 9:05am
Nucleus RadioPharma unveils manufacturing pact with ARTBIO
May 7, 2024 8:47am
API Innovation Center looks to bolster US cancer drug supplies
Apr 10, 2024 2:29pm
